Visible Genetics Inc.(VGIN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (90)	9/13/1997 11:14:00 AM
From: Richard Haugland	of 337

Very positive article on VGINF from TheStreet.com. They e-mailed it to me overnight as part of their daily updates (free on registration). Sorry that copyright restrictions prevent me from posting it. Among other matters, they identify that Ardsley Partners and Essex Investment Management may be moving into the stock and Oracle hedge fund and T. Rowe Price mutual funds have investments already. They also blamed the decline after the IPO (at $11.50) on lack of Wall Street support and the move of analyst, Jackie Siegel, to another company, where she hasn't picked it up. Also the company has no other sell-side analyst coverage, except for First Marathon Securities in Toronto, which was a co-manager of the IPO. The article noted good acceptance of the VGINF products by companies such as Genentec and Millenium and acknowledged low sales so far but an expected pickup in the fourth quarter as VGINF starts to get its product out. VGINF was apparently TheStreet.com's pick of the week for an under $10 stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next